BOOST II: Benefits Of Oxygen Saturation Targeting Study

Phase 3

• Conditions: Preterm infants; Reproductive Health and Childbirth - Normal pregnancy; Reproductive Health and Childbirth - Childbirth and postnatal care

• Registration Number: ACTRN12605000055606
• Lead Sponsor: HMRC Clinical Trials Centre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-08-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 1200

Inclusion Criteria

a) born <28 weeks gestation b) less than 24 hours of agec) there is informed consent by parent(s) or legal guardian

Exclusion Criteria

a) There is a known congenital anomaly that could affect oxygenation or developmentb) attendance for follow-up for 2 years is judged unlikely.

Study & Design

• Study Type: Interventional
• Study Design: Not specified